Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $14.0650 (10.1%) ($14.0650 - $14.0650) on Tue. Oct. 4, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.14% (three month average) | RSI | 54 | Latest Price | $14.0650(10.1%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX advances 2.5% a day on average for past five trading days. | Weekly Trend | BCRX declines -1% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) XLK(31%) URA(30%) VT(30%) VUG(30%) BLOK(29%) | Factors Impacting BCRX price | BCRX will decline at least -2.07% in a week (0% probabilities). SMH(-13%) VIXM(-12%) UUP(-11%) VXX(-2%) EDOC(-2%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.07% (StdDev 4.14%) | Hourly BBV | 1.4 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $12.96(8.53%) | 10 Day Moving Average | $12.77(10.14%) | 20 Day Moving Average | $13.07(7.61%) | To recent high | -5.1% | To recent low | 30.5% | Market Cap | $2.481b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |